Healthcare -
Biotechnology - NASDAQ - US
$ 0.54
-5.92 %
$ 18.8 M
Market Cap
-0.57
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Ocean Biomedical, Inc.
| Revenue | 0 |
| Cost Of Revenue | 0 |
| Gross Profit | 0 |
| Operating Expenses | 2.48 M |
| Operating Income | -2.48 M |
| Other Expenses | 112 M |
| Net Income | -114 M |
Income Statement
Millions
| Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|
| REVENUE | ||||
| Revenue | 0 | 0 | 0 | 0 |
| GROSS PROFIT | ||||
| Cost Of Revenue | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 |
| OPERATING INCOME | ||||
| Operating Expenses | 2.5 | 62.3 | 1.7 | 0.2 |
| Selling, General and Administrative Expenses | 2.5 | 28.4 | 1.6 | 0.2 |
| Research and Development Expenses | 0 | 33.9 | 49 K | 35 K |
| Operating Income | (2.5) | (62.3) | (1.7) | (0.2) |
| PRE-TAX INCOME | ||||
| Interest Income Expense | 691 | 0 | 0 | 0 |
| Total Other Income | 1.5 | 61.8 | 1 K | 0 |
| Pre-Tax Income | (1.0) | (62.3) | (1.7) | (0.2) |
| NET INCOME | ||||
| Tax Provision | 0 | (0.2) | (0.2) | (0.2) |
| Net Income | 0.6 | (62.3) | (1.7) | (0.2) |
| EPS | 0.0263 | 4.71 | 0.0818 | 0.0115 |